Read more:
Bone Therapeutics provides fourth quarter 2020 business update and 2021 outlook

See the rest here:
Jounce Therapeutics to Present at Upcoming Investor Conferences in January

See the rest here:
Ceapro Inc. to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference

Read the original here:
Leading BioSciences Announces Positive Topline Data from Open-Label Gastrointestinal Surgery Study

See the original post here:
Denali Therapeutics Announces Significant Program Progress and Expected Key Milestones in 2021 for Its Broad Therapeutic Portfolio in...

More here:
Vericel to Present at the 23rd Annual Needham Growth Conference on Friday, January 15, 2021

Go here to read the rest:
Pacific Biosciences Announces Appointments of Mark Van Oene as Chief Operating Officer and Peter Fromen as Chief Commercial Officer

Read this article:
Aleafia Health Enters Definitive Supply Agreement with European Pharmaceutical Producer Apipharm

See the original post here:
Novan to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference

Visit link:
AzurRx BioPharma CEO Issues Letter to Shareholders

Read more:
Data from Vallon Pharmaceuticals’ ADAIR Selected for Symposia Presentation at the Virtual 2021 APSARD Annual Meeting

Follow this link:
Tauriga Sciences Inc. Increases its Product Liability Insurance Coverage to $10,000,000

See the article here:
Tauriga Sciences Inc. Showcases its Virtual Booth as a Corporate Exhibitor at 2021 CTIC Capital Pre-J.P. Morgan Healthcare Investor Summit This...

Read the original:
VALNEVA - Déclaration d’actions et de droits de vote – DECEMBRE 2020

See the rest here:
GENFIT Informs its Shareholders of Certain Procedures for the Extraordinary General Meeting of January 13, 2021

Go here to read the rest:
Celon Pharma Announces Positive Falkieri Phase II Results in Treatment-Resistant Bipolar Depression

The rest is here:
Generex Biotechnology Announces Investor Conference Call Scheduled for Friday February 5, 2021 at 9:00 AM

See the original post:
Ocugen Inc. Regains Compliance with Nasdaq Bid Price Rule

Read the original:
CEO Dr. Johnson Lau Contracts COVID-19

See original here:
Evaxion Biotech Announces Filing of Registration Statement in the U.S. for Proposed Initial Public Offering of Securities